FDA hits Novartis with unexpected 3-month delay on MS drug ofatumumab

·

·

FDA hits Novartis with unexpected 3-month delay on MS drug ofatumumab

Novartis had planned to play up ofatumumab’s convenient dosing schedule in marketing the drug to MS patients. (Novartis). Share Facebook Twitter LinkedIn Email Print. Last week, Novartis was touting positive data showing its repurposed leukemia drug …
See Original Article

Someone Just Made a Big Bullish Options Bet on a Singapore ETF

… of 5,044 iShares MSCI Singapore ETF calls traded on Tuesday, compared with a 20-day average of 222, according to data compiled by Bloomberg.
See Original Article

3M names GE executive as new CFO

3M has appointed a top GE Healthcare executive as its new chief financial officer. The Maplewood-based company said current CFO Nick Gangestad is retiring after a 33-year career at 3M. Monish Patolawala, 51, has been GE Healthcare’s CFO since 2015.
See Original Article

Comcast rejects calls for outside investigation of NBC's handling of sexual harassment

Comcast shareholders, led by Chairman Brian Roberts, rejected three proposals from investors, including a demand for an outside investigation into sexual harassment at NBC News. The Philadelphia-based cable giant also tossed out shareholder requests …
See Original Article

The Inequality Theme Will Be Big: Macro Man (Audio)

Bloomberg's Cameron Crise discusses how crisis response policies are likely to exacerbate inequality across both households and corporations.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.